HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition.

Danilo Ranieri (1) , Francesca Belleudi (1) , Alessandra Magenta (1) , Maria Rosaria Torrisi (1, 2)

1 Department of Molecular Medicine
2 Azienda Ospedaliera Sant'Andrea

The E5 oncoprotein of the human papillomavirus type 16 (HPV16 E5) deregulates epithelial homeostasis through the modulation of receptor tyrosine kinases and their signaling. Accordingly, the fibroblast growth factor receptor 2b (FGFR2b/KGFR), epithelial splicing transcript variant of the FGFR2, is down-modulated by the viral protein expression, leading to impairment of keratinocyte differentiation. Here, we report that, in cell models of transfected human keratinocytes as well as in cervical epithelial cells containing episomal HPV16, the down-regulation of FGFR2b induced by 16E5 is associated with the aberrant expression of the mesenchymal FGFR2c isoform as a consequence of splicing switch: in fact, quantitative RT-PCR analysis showed that this molecular event is transcriptionally regulated by the epithelial splicing regulatory proteins 1 and 2 (ESRP1 and ESRP2) and is able to produce effects synergistic with those caused by TGFβ treatment. Immunofluorescence analysis revealed that this altered FGFR2 splicing leads to changes in the specificity for the ligands FGFs and in the cellular response, triggering epithelial-mesenchymal transition (EMT). Through 16E5 or FGFR2 silencing as well as inhibition of FGFR2 activity we demonstrated the direct role of the viral protein in the receptor isoform switching and EMT, suggesting that these early molecular events during HPV infection might represent additional mechanisms driving cervical transformation and tumor progression.

Mots clés: HPV16 E5; FGFR; epithelial-mesenchymal transition; human keratinocytes; Cell Biology

Domaines: Biologie cellulaire; Biochimie, Biologie Moléculaire

Danilo Ranieri, Francesca Belleudi, Alessandra Magenta, Maria Rosaria Torrisi. HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition.. International Journal of Cancer, 2015, 137 (1), pp.61-72. ⟨10.1002/ijc.29373⟩. ⟨pasteur-01203119⟩